Hunter Perkins Capital Management, LLC Haemonetics Corp Transaction History
Hunter Perkins Capital Management, LLC
- $423 Million
- Q2 2025
A detailed history of Hunter Perkins Capital Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 7,100 shares of HAE stock, worth $370,833. This represents 0.13% of its overall portfolio holdings.
Number of Shares
7,100Holding current value
$370,833% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
54MCall Options Held
637KPut Options Held
300K-
Black Rock Inc. New York, NY5.96MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$259 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$223 Million0.26% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$115 Million0.09% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$112 Million0.03% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.68B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...